Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nepoklonov Av"'
Publikováno v:
Pharmaceutical Chemistry Journal. 47:517-520
Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg demonstrated anti-inflammatory activity and decreased statistically significantly the intensity of the exudative reaction in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::124c6ab0aaa4477262db610afdc7d29e
https://doi.org/10.1007/s11094-014-0994-x
https://doi.org/10.1007/s11094-014-0994-x
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2016; Vol. 79 (1), pp. 12-4.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2014; Vol. 77 (5), pp. 3-5.
Autor:
Kotel'nikova SO, Nepoklonov AV, Kokshenev II, Ivanova EA, Kraĭneva VA, Val'dman EA, Garibova TL, Voronina TA
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2012; Vol. 112 (9), pp. 63-6.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2012; Vol. 75 (11), pp. 3-6.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2011; Vol. 74 (7), pp. 9-12.